Guard Therapeutics International AB (GUARD) - Cash Flow Conversion Efficiency

Latest as of September 2025: -1.630x

Based on the latest financial reports, Guard Therapeutics International AB (GUARD) has a cash flow conversion efficiency ratio of -1.630x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-90.70 Million ≈ $-9.76 Million USD) by net assets (Skr55.63 Million ≈ $5.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guard Therapeutics International AB market cap and net worth for the company's overall valuation and market capitalisation.

Guard Therapeutics International AB - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Guard Therapeutics International AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guard Therapeutics International AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guard Therapeutics International AB ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Guard Therapeutics International AB to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
LSL Property Services Plc LSE:LSL	0.034x
EQTEC plc LSE:EQT	-0.273x
Kandal M Venture Limited Class A Ordinary Shares NASDAQ:FMFC	0.049x
Mid Wynd International Investment Trust plc LSE:MWY	0.002x
Adherium Ltd AU:ADR	9.437x
De La Rue PLC LSE:DLAR	2.021x
Prophecy International Holdings Ltd AU:PRO	-2.309x
Capricorn Energy PLC LSE:CNE	0.335x

Annual Cash Flow Conversion Efficiency for Guard Therapeutics International AB (2012–2024)

The table below shows the annual cash flow conversion efficiency of Guard Therapeutics International AB from 2012 to 2024. View Guard Therapeutics International AB (GUARD) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr37.97 Million ≈ $4.09 Million	Skr-94.75 Million ≈ $-10.20 Million	-2.496x	-43.52%
2023-12-31	Skr66.73 Million ≈ $7.18 Million	Skr-116.05 Million ≈ $-12.49 Million	-1.739x	-201.96%
2022-12-31	Skr177.36 Million ≈ $19.09 Million	Skr-102.14 Million ≈ $-10.99 Million	-0.576x	-30.46%
2021-12-31	Skr175.78 Million ≈ $18.92 Million	Skr-77.59 Million ≈ $-8.35 Million	-0.441x	+7.34%
2020-12-31	Skr79.69 Million ≈ $8.58 Million	Skr-37.96 Million ≈ $-4.09 Million	-0.476x	+58.36%
2019-12-31	Skr52.62 Million ≈ $5.66 Million	Skr-60.21 Million ≈ $-6.48 Million	-1.144x	-105.75%
2018-12-31	Skr-2.94 Million ≈ $-316.28K	Skr-58.46 Million ≈ $-6.29 Million	19.890x	+1063.17%
2017-12-31	Skr31.96 Million ≈ $3.44 Million	Skr-66.01 Million ≈ $-7.10 Million	-2.065x	-33.35%
2016-12-31	Skr30.34 Million ≈ $3.26 Million	Skr-46.98 Million ≈ $-5.06 Million	-1.549x	-123.61%
2015-12-31	Skr42.69 Million ≈ $4.59 Million	Skr-29.56 Million ≈ $-3.18 Million	-0.693x	-427.08%
2014-12-31	Skr52.25 Million ≈ $5.62 Million	Skr-6.87 Million ≈ $-738.89K	-0.131x	-18.18%
2013-12-31	Skr25.42 Million ≈ $2.74 Million	Skr-2.83 Million ≈ $-304.12K	-0.111x	-134.81%
2012-12-31	Skr30.58 Million ≈ $3.29 Million	Skr-1.45 Million ≈ $-155.83K	-0.047x	--

About Guard Therapeutics International AB

ST:GUARD Sweden Biotechnology

Market Cap

$3.19 Million

Skr29.61 Million SEK

Market Cap Rank

#29455 Global

#665 in Sweden

Share Price

Skr1.47

Change (1 day)

+1.24%

52-Week Range

Skr0.95 - Skr25.90

All Time High

Skr3260.75